357 related articles for article (PubMed ID: 2441174)
1. Antihypertensive and renal effects of captopril in spontaneously hypertensive rats: evidence against a role of the kallikrein-kinin system.
Filep J; Rigter B; Földes-Filep E
J Cardiovasc Pharmacol; 1987 Aug; 10(2):222-7. PubMed ID: 2441174
[TBL] [Abstract][Full Text] [Related]
2. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
3. Effects of captopril on the urinary excretion of prostanoids and kallikrein in spontaneously hypertensive rats.
Säynävälammi P
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):285-90. PubMed ID: 3541494
[TBL] [Abstract][Full Text] [Related]
4. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
McCaa RE
Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
[TBL] [Abstract][Full Text] [Related]
5. Effect of aprotinin-induced kallikrein inhibition on the cardiovascular and renal action of captopril in diuretic-treated dogs.
Vemulapalli S; Chiu PJ
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):109-23. PubMed ID: 6191727
[TBL] [Abstract][Full Text] [Related]
6. Effects of a kinin antagonist on renal function in rats.
Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
[TBL] [Abstract][Full Text] [Related]
7. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
[TBL] [Abstract][Full Text] [Related]
8. The kallikrein-kinin system in blood pressure homeostasis.
Lee TC; Kushiro T; Gassia JP; Girolami JP; Lupu AN; Maxwell MH
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():255s-258s. PubMed ID: 94277
[TBL] [Abstract][Full Text] [Related]
9. [Renal kallikrein-kinin system and control of blood pressure (author's transl)].
Distler A; Wolff HP
Klin Wochenschr; 1979 Oct; 57(19):1037-45. PubMed ID: 392177
[TBL] [Abstract][Full Text] [Related]
10. Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
Chen K; Zhang X; Dunham EW; Zimmerman BG
Hypertension; 1996 Jan; 27(1):85-9. PubMed ID: 8591894
[TBL] [Abstract][Full Text] [Related]
11. Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition.
Clappison BH; Anderson WP; Johnston CI
Kidney Int; 1981 Nov; 20(5):615-20. PubMed ID: 6283229
[TBL] [Abstract][Full Text] [Related]
12. Brain kinins are responsible for the pressor effect of intracerebroventricular captopril in spontaneously hypertensive rats.
Madeddu P; Glorioso N; Soro A; Tonolo G; Manunta P; Troffa C; Demontis MP; Varoni MV; Anania V
Hypertension; 1990 Apr; 15(4):407-12. PubMed ID: 2180818
[TBL] [Abstract][Full Text] [Related]
13. Synergic effects of kallikrein-kinin and prostaglandins on renin release on infusion of isolated hog kidney with aldosterone.
Gotoh S; Ogihara T; Nakamaru M; Ohde H; Higaki J; Otsuka A; Tabuchi Y; Kumahara Y; Nishino T
Life Sci; 1984 May; 34(20):1913-8. PubMed ID: 6203005
[TBL] [Abstract][Full Text] [Related]
14. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
[TBL] [Abstract][Full Text] [Related]
15. The mechanism of the hypotensive effect of captopril (converting enzyme inhibitor) with special reference to the kallikrein-kinin and renin-angiotensin systems.
Iimura O; Shimamoto K; Tanaka S; Hosoda S; Nishitani T; Ando T; Masuda A
Jpn J Med; 1986 Feb; 25(1):34-9. PubMed ID: 3520064
[TBL] [Abstract][Full Text] [Related]
16. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
Johnston CI; Clappison BH; Anderson WP; Yasujima M
Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of cicletanine on hypertension-induced decreases in the renal kallikrein-kinin and prostaglandin systems in stroke-prone spontaneously hypertensive rats.
Emond C; Bompart G; Rakotoarivony J; Bascands JL; Pecher C; Adam A; Tarrade T; Berthet P; Girolami JP
J Cardiovasc Pharmacol; 1992 Oct; 20(4):601-8. PubMed ID: 1280717
[TBL] [Abstract][Full Text] [Related]
19. Altered blood pressure and renin responses to converting enzyme inhibition after aprotinin-induced kallikrein-kinin-system blockade.
Overlack A; Stumpe KO; Kühnert M; Heck I
Clin Sci (Lond); 1980 Dec; 59 Suppl 6():129s-132s. PubMed ID: 6160938
[TBL] [Abstract][Full Text] [Related]
20. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
